Edwards Lifesciences Pre-Tax Profit Margin 2010-2024 | EW
Current and historical pre-tax profit margin for Edwards Lifesciences (EW) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Edwards Lifesciences pre-tax profit margin for the three months ending September 30, 2024 was .
| Edwards Lifesciences Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $6.34B | $1.74B | 27.36% |
| 2024-06-30 | $6.23B | $1.72B | 27.61% |
| 2024-03-31 | $6.14B | $1.61B | 26.19% |
| 2023-12-31 | $6.01B | $1.60B | 26.63% |
| 2023-09-30 | $5.35B | $1.52B | 28.45% |
| 2023-06-30 | $5.42B | $1.54B | 28.40% |
| 2023-03-31 | $5.50B | $1.73B | 31.45% |
| 2022-12-31 | $5.38B | $1.77B | 32.83% |
| 2022-09-30 | $5.36B | $1.68B | 31.39% |
| 2022-06-30 | $5.36B | $1.67B | 31.15% |
| 2022-03-31 | $5.36B | $1.75B | 32.65% |
| 2021-12-31 | $5.23B | $1.70B | 32.52% |
| 2021-09-30 | $5.10B | $1.68B | 33.01% |
| 2021-06-30 | $4.93B | $1.66B | 33.60% |
| 2021-03-31 | $4.48B | $0.94B | 21.03% |
| 2020-12-31 | $4.39B | $0.92B | 20.90% |
| 2020-09-30 | $4.37B | $0.88B | 20.07% |
| 2020-06-30 | $4.32B | $0.82B | 18.86% |
| 2020-03-31 | $4.48B | $1.25B | 27.97% |
| 2019-12-31 | $4.35B | $1.17B | 26.84% |
| 2019-09-30 | $4.15B | $0.85B | 20.45% |
| 2019-06-30 | $3.97B | $0.80B | 20.08% |
| 2019-03-31 | $3.82B | $0.78B | 20.30% |
| 2018-12-31 | $3.72B | $0.76B | 20.46% |
| 2018-09-30 | $3.64B | $1.09B | 29.93% |
| 2018-06-30 | $3.55B | $1.05B | 29.61% |
| 2018-03-31 | $3.45B | $1.01B | 29.18% |
| 2017-12-31 | $3.44B | $1.04B | 30.14% |
| 2017-09-30 | $3.32B | $0.91B | 27.50% |
| 2017-06-30 | $3.23B | $0.89B | 27.37% |
| 2017-03-31 | $3.15B | $0.85B | 26.92% |
| 2016-12-31 | $2.96B | $0.74B | 24.87% |
| 2016-09-30 | $2.87B | $0.70B | 24.56% |
| 2016-06-30 | $2.74B | $0.67B | 24.43% |
| 2016-03-31 | $2.60B | $0.64B | 24.72% |
| 2015-12-31 | $2.49B | $0.62B | 24.98% |
| 2015-09-30 | $2.44B | $0.59B | 24.13% |
| 2015-06-30 | $2.43B | $0.56B | 22.99% |
| 2015-03-31 | $2.39B | $1.23B | 51.46% |
| 2014-12-31 | $2.32B | $1.14B | 49.27% |
| 2014-09-30 | $2.24B | $1.11B | 49.60% |
| 2014-06-30 | $2.13B | $1.09B | 51.20% |
| 2014-03-31 | $2.07B | $0.40B | 19.22% |
| 2013-12-31 | $2.05B | $0.51B | 25.02% |
| 2013-09-30 | $2.02B | $0.53B | 26.29% |
| 2013-06-30 | $1.97B | $0.52B | 26.57% |
| 2013-03-31 | $1.94B | $0.49B | 25.45% |
| 2012-12-31 | $1.90B | $0.39B | 20.43% |
| 2012-09-30 | $1.82B | $0.34B | 18.58% |
| 2012-06-30 | $1.78B | $0.30B | 16.98% |
| 2012-03-31 | $1.73B | $0.29B | 16.50% |
| 2011-12-31 | $1.68B | $0.29B | 16.97% |
| 2011-09-30 | $1.64B | $0.29B | 17.43% |
| 2011-06-30 | $1.58B | $0.29B | 18.64% |
| 2011-03-31 | $1.51B | $0.29B | 18.99% |
| 2010-12-31 | $1.45B | $0.27B | 18.52% |
| 2010-09-30 | $1.40B | $0.26B | 18.54% |
| 2010-06-30 | $1.38B | $0.29B | 20.88% |
| 2010-03-31 | $1.35B | $0.29B | 21.11% |
| 2009-12-31 | $1.32B | $0.30B | 22.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.952B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.348B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| DexCom (DXCM) | United States | $33.759B | 50.84 |
| Waters (WAT) | United States | $23.998B | 35.49 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Globus Medical (GMED) | United States | $12.635B | 32.00 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Masimo (MASI) | United States | $9.509B | 46.01 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Integra LifeSciences Holdings (IART) | United States | $2.016B | 10.53 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| Pacific Biosciences Of California (PACB) | United States | $0.427B | 0.00 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |